real‐world evidence

Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study

Alkabbani W, Crisafulli S, Paik JM, Tavakkoli A, Bykov K, Glynn RJ, Wexler DJ, Patorno E. Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe[...]

By afschroeder • June 5, 2026

Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real-world patient data repository

Farber HW, Chakinala MM, Cho M, Frantz RP, Frick A, Lancaster L, Milligan S, Oudiz R, Panjabi S, Tsang Y, Nathan SD. Characteristics of patients[...]

By sjmartinez • July 10, 2023